Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Iop, A.
Right arrow Articles by Bonura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iop, A.
Right arrow Articles by Bonura, S.
Related Collections
Right arrow 2004 - Review Articles
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 15:712-720, 2004
© 2004 European Society for Medical Oncology

Review Article

Fatigue in cancer patients receiving chemotherapy: an analysis of published studies

Received 19 June 2003; revised 12 December 2003; accepted 19 December 2003

ABSTRACT

Fatigue is a subjective experience that affects everybody. In healthy individuals, it can be considered a physiological response to physical or psychological stress. In people with specific diseases, however, fatigue often represents one of the most significant problems. Fatigue can be caused by many factors, both intrinsic to the patient and extrinsic, such as therapeutic interventions. This review, based on published studies, has been conducted with the aim of presenting a critical discussion of the available information on the characteristics, causes and potential treatments of fatigue in cancer patients receiving chemotherapy. The incidence of fatigue in these patients, the methods for measuring and evaluating fatigue, and possible therapeutic options are discussed. An appraisal of the toxicity of various chemotherapeutic agents is also presented. Although fatigue is now an ever more considered aspect of the toxicity of chemotherapy, it remains difficult to establish what standard should be used to make a quali-quantitative evaluation of this symptom. Furthermore, in the absence of a clear demonstration of the efficacy of some therapies, the management of cancer-related fatigue remains poorly defined (except for the treatment of anemia-related fatigue). New randomized clinical trials are necessary to indicate the best strategies for tackling this important problem.

A. Iop*, A. M. Manfredi and S. Bonura

Oncology Unit, General Hospital, Latisana, Italy

Key words: chemotherapy, fatigue, toxicity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
O. Minton, A. Richardson, M. Sharpe, M. Hotopf, and P. Stone
A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
J Natl Cancer Inst, August 20, 2008; 100(16): 1155 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
R. J. Muller and D. Baribeault
Extended-dosage-interval regimens of erythropoietic agents in chemotherapy-induced anemia
Am. J. Health Syst. Pharm., December 15, 2007; 64(24): 2547 - 2556.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Spazzapan, A. Bearz, and U. Tirelli
Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
Ann. Onc., October 1, 2004; 15(10): 1576 - 1576.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.